PHARMACOKINETIC PROPERTIES OF A NEW KAPPA-OPIOID ANALGESIC RU-1205 COMPOUND AT A SINGLE PERORAL ADMINISTRATION
The aim of the study is the investigation of the pharmacokinetic properties of the RU-1205 compound, with previously identified kappa-agonistic and analgesic effects, at a single oral administration, as well as comparison of the relationship between its pharmacokinetic and analgesic properties.Mater...
Main Authors: | A. A. Spasov, L. A. Smirnova, O. Yu. Grechko, N. V. Eliseeva, Yu. V. Lifanova, A. I. Rashchenko, O. N. Zhukovskaya, A. S. Morkovnik, V. A. Anisimova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
2021-07-01
|
Series: | Farmaciâ i Farmakologiâ (Pâtigorsk) |
Subjects: | |
Online Access: | https://www.pharmpharm.ru/jour/article/view/833 |
Similar Items
-
Distribution, excretion and metabolic pathways of a single parenteral administration of kappa-opioid receptor agonist RU-1205
by: Alexander A. Spasov, et al.
Published: (2021-06-01) -
Effect of adjuvant drugs on the analgesic activity of opioid morphine analgesics and compound RU-1205
by: Alexander A. Spasov, et al.
Published: (2021-09-01) -
Analgesic Activity of the Kappa Opioid Receptor Agonist - RU-1205 in Rats / Spasov AA ... [et al.]
by: AA, Spasov, et al.
Published: (2018) -
Study of aversive and p38 mapk-inhibitory properties of kappa-agonist with analgesic activity – compound RU-1205
by: Alexander A. Spasov, et al.
Published: (2020-09-01) -
Peroral endoscopic full and partial-thickness myotomy. A viability study in an animal model
by: C.D. Quiroz-Guadarrama, et al.
Published: (2013-10-01)